ACCUSTEM SCIENCES, INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-252.6K | $-485.9K | $-399.9K | $-401.4K | $-440.4K | $-328.2K | $-278.2K | $-526.6K |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | — | $0 | $105 | $313 | $907 | $907 | $908 |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | $15.2K | — | — | $18.1K | — | — | $18.2K |
| Net Cash from Operating Activities | — | $-374.2K | — | — | $-290.2K | — | — | $-237.4K |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $372.5K | — | — | $321.5K | — | — | $225.2K |
| Net Change in Cash | — | $-1.7K | — | — | $31.3K | — | — | $-12.1K |
| Free Cash Flow | — | — | — | — | — | — | — | — |